High-risk patients: modern treatment strategy

被引:0
|
作者
Nebieridze, D. V. [1 ]
Meliya, A. [2 ]
机构
[1] State Res Ctr Prevent Med, Moscow, Russia
[2] Cardiol Clin Guli, Tbilisi, Georgia
来源
关键词
High-risk patients; antihypertensive therapy; lipid-lowering therapy; anti-aggregant therapy; Aspirin (R) Cardio; DISEASE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This review summarizes modern views on high-risk patients as atherosclerosis-free individuals. The importance of high-risk approach is explained by the fact that this group encompasses the majority of cardiac patients, as well as the majority of cardiovascular events. Therefore, early diagnostics and adequate management of high-risk patients could substantially reduce the incidence of cardiovascular events. The modern treatment strategy for high-risk patients requires pharmaceutical intervention, and has the same principles as the treatment of patients with diagnosed cardiovascular disease. Such components of pharmaceutical treatment as antihypertensive, lipid-lowering, and anti-aggregant therapy are discussed in detail.
引用
收藏
页码:97 / 101
页数:5
相关论文
共 50 条
  • [41] Multiple Myeloma: Defining the High-Risk Patient and Determining the Optimal Treatment Strategy
    Schecter, Jordan
    Lentzsch, Suzanne
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (04) : 277 - 283
  • [42] Multiple Myeloma: Defining the High-Risk Patient and Determining the Optimal Treatment Strategy
    Jordan Schecter
    Suzanne Lentzsch
    Current Hematologic Malignancy Reports, 2013, 8 : 277 - 283
  • [43] Current Role of Lipoprotein Apheresis in the Treatment of High-Risk Patients
    Julius, Ulrich
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2018, 5 (02)
  • [44] Treatment options for multiple myeloma patients with high-risk disease
    Ailawadhi, Sikander
    Masood, Aisha
    Sher, Taimur
    Miller, Kena C.
    Wood, Margaret
    Lee, Kelvin
    Chanan-Khan, Asher
    MEDICAL ONCOLOGY, 2010, 27 : 53 - 61
  • [45] Pain Among High-Risk Patients on Methadone Maintenance Treatment
    Voon, Pauline
    Hayashi, Kanna
    Milloy, M-J
    Nguyen, Paul
    Wood, Evan
    Montaner, Julio
    Kerr, Thomas
    JOURNAL OF PAIN, 2015, 16 (09): : 887 - 894
  • [46] Emerging treatment options for patients with high-risk myelodysplastic syndrome
    Bewersdorf, Jan Philipp
    Carraway, Hetty
    Prebet, Thomas
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [47] Treatment options for multiple myeloma patients with high-risk disease
    Sikander Ailawadhi
    Aisha Masood
    Taimur Sher
    Kena C. Miller
    Margaret Wood
    Kelvin Lee
    Asher Chanan-Khan
    Medical Oncology, 2010, 27 : 53 - 61
  • [48] Significance of ONTARGET Results for the Treatment of cardiovascular High-risk Patients
    Eber, B.
    JOURNAL FUR KARDIOLOGIE, 2008, 15 (5-6): : 189 - 191
  • [49] Effect of PSA on equal treatment of high-risk patients.
    Ferenczi, Basil
    Frankel, Jason
    Jung, Nathan
    Porter, Christopher
    Flores, John Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [50] DECITABINE IN TREATMENT OF PATIENTS WITH INTERMEDIATEOR HIGH-RISK MYELODYSPLASTIC SYNDROMES
    Kalinichenko, E.
    Ponteleeva, I.
    Fiodarava, A.
    Iskrov, I.
    Uss, A.
    LEUKEMIA RESEARCH, 2017, 55 : S71 - S72